Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME)

Protocol for a randomised controlled trial

Sarah Baos, Amberly Brigden, Emma Anderson, William Hollingworth, Simon Price, Nicola Mills, Lucy Beasant, Daisy Gaunt, Kirsty Garfield, Chris Metcalfe, Roxanne Parslow, Harriet Downing, David Kessler, John Macleod, Paul Stallard, Hans Knoop, Elise Van de Putte, Sanne Nijhof, Gijs Bleijenberg, Esther Crawley

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a relatively common and disabling condition. The National Institute for Health and Clinical Excellence (NICE) recommends Cognitive Behavioural Therapy (CBT) as a treatment option for paediatric CFS/ME because there is good evidence that it is effective. Despite this, most young people in the UK are unable to access local specialist CBT for CFS/ME. A randomised controlled trial (RCT) showed FITNET was effective in the Netherlands but we do not know if it is effective in the National Health Service (NHS) or if it is cost-effective. This trial will investigate whether FITNET-NHS is clinically effective and cost-effective in the NHS. Methods: Seven hundred and thirty-four paediatric patients (aged 11-17 years) with CFS/ ME will be randomised (1:1) to receive either FITNET-NHS (online CBT) or Activity Management (delivered via video call). The internal pilot study will use integrated qualitative methods to examine the feasibility of recruitment and the acceptability of treatment. The full trial will assess whether FITNET-NHS is clinically effective and cost-effective. The primary outcome is disability at 6 months, measured using the SF-36-PFS (Physical Function Scale) questionnaire. Cost-effectiveness is measured via cost-utility analysis from an NHS perspective. Secondary subgroup analysis will investigate the effectiveness of FITNET-NHS in those with co-morbid mood disorders. Discussion: If FITNET-NHS is found to be feasible and acceptable (internal pilot) and effective and cost-effective (full trial), its provision by the NHS has the potential to deliver substantial health gains for the large number of young people suffering from CFS/ME but unable to access treatment because there is no local specialist service. This trial will provide further evidence evaluating the delivery of online CBT to young people with chronic conditions.

Original languageEnglish
Article number136
Pages (from-to)1-12
Number of pages12
JournalTrials
Volume19
Issue number1
DOIs
Publication statusPublished - 22 Feb 2018

Fingerprint

Chronic Fatigue Syndrome
National Health Programs
Internet
Cost-Benefit Analysis
Fatigue
Randomized Controlled Trials
Pediatrics
Cognitive Therapy
Costs and Cost Analysis
National Institutes of Health (U.S.)
Mood Disorders
Netherlands
Therapeutics

Keywords

  • Activity management
  • CBT
  • CFS/ME
  • Chronic fatigue syndrome
  • E-counselling
  • E-health
  • E-therapy
  • Myalgic encephalomyelitis
  • Online systems
  • Paediatrics

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Cite this

Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) : Protocol for a randomised controlled trial. / Baos, Sarah; Brigden, Amberly; Anderson, Emma; Hollingworth, William; Price, Simon; Mills, Nicola; Beasant, Lucy; Gaunt, Daisy; Garfield, Kirsty; Metcalfe, Chris; Parslow, Roxanne; Downing, Harriet; Kessler, David; Macleod, John; Stallard, Paul; Knoop, Hans; Van de Putte, Elise; Nijhof, Sanne; Bleijenberg, Gijs; Crawley, Esther.

In: Trials, Vol. 19, No. 1, 136, 22.02.2018, p. 1-12.

Research output: Contribution to journalArticle

Baos, S, Brigden, A, Anderson, E, Hollingworth, W, Price, S, Mills, N, Beasant, L, Gaunt, D, Garfield, K, Metcalfe, C, Parslow, R, Downing, H, Kessler, D, Macleod, J, Stallard, P, Knoop, H, Van de Putte, E, Nijhof, S, Bleijenberg, G & Crawley, E 2018, 'Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): Protocol for a randomised controlled trial', Trials, vol. 19, no. 1, 136, pp. 1-12. https://doi.org/10.1186/s13063-018-2500-3
Baos, Sarah ; Brigden, Amberly ; Anderson, Emma ; Hollingworth, William ; Price, Simon ; Mills, Nicola ; Beasant, Lucy ; Gaunt, Daisy ; Garfield, Kirsty ; Metcalfe, Chris ; Parslow, Roxanne ; Downing, Harriet ; Kessler, David ; Macleod, John ; Stallard, Paul ; Knoop, Hans ; Van de Putte, Elise ; Nijhof, Sanne ; Bleijenberg, Gijs ; Crawley, Esther. / Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) : Protocol for a randomised controlled trial. In: Trials. 2018 ; Vol. 19, No. 1. pp. 1-12.
@article{45b1bbb63df44dd5b3993e2caa3d87e1,
title = "Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): Protocol for a randomised controlled trial",
abstract = "Background: Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a relatively common and disabling condition. The National Institute for Health and Clinical Excellence (NICE) recommends Cognitive Behavioural Therapy (CBT) as a treatment option for paediatric CFS/ME because there is good evidence that it is effective. Despite this, most young people in the UK are unable to access local specialist CBT for CFS/ME. A randomised controlled trial (RCT) showed FITNET was effective in the Netherlands but we do not know if it is effective in the National Health Service (NHS) or if it is cost-effective. This trial will investigate whether FITNET-NHS is clinically effective and cost-effective in the NHS. Methods: Seven hundred and thirty-four paediatric patients (aged 11-17 years) with CFS/ ME will be randomised (1:1) to receive either FITNET-NHS (online CBT) or Activity Management (delivered via video call). The internal pilot study will use integrated qualitative methods to examine the feasibility of recruitment and the acceptability of treatment. The full trial will assess whether FITNET-NHS is clinically effective and cost-effective. The primary outcome is disability at 6 months, measured using the SF-36-PFS (Physical Function Scale) questionnaire. Cost-effectiveness is measured via cost-utility analysis from an NHS perspective. Secondary subgroup analysis will investigate the effectiveness of FITNET-NHS in those with co-morbid mood disorders. Discussion: If FITNET-NHS is found to be feasible and acceptable (internal pilot) and effective and cost-effective (full trial), its provision by the NHS has the potential to deliver substantial health gains for the large number of young people suffering from CFS/ME but unable to access treatment because there is no local specialist service. This trial will provide further evidence evaluating the delivery of online CBT to young people with chronic conditions.",
keywords = "Activity management, CBT, CFS/ME, Chronic fatigue syndrome, E-counselling, E-health, E-therapy, Myalgic encephalomyelitis, Online systems, Paediatrics",
author = "Sarah Baos and Amberly Brigden and Emma Anderson and William Hollingworth and Simon Price and Nicola Mills and Lucy Beasant and Daisy Gaunt and Kirsty Garfield and Chris Metcalfe and Roxanne Parslow and Harriet Downing and David Kessler and John Macleod and Paul Stallard and Hans Knoop and {Van de Putte}, Elise and Sanne Nijhof and Gijs Bleijenberg and Esther Crawley",
year = "2018",
month = "2",
day = "22",
doi = "10.1186/s13063-018-2500-3",
language = "English",
volume = "19",
pages = "1--12",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME)

T2 - Protocol for a randomised controlled trial

AU - Baos, Sarah

AU - Brigden, Amberly

AU - Anderson, Emma

AU - Hollingworth, William

AU - Price, Simon

AU - Mills, Nicola

AU - Beasant, Lucy

AU - Gaunt, Daisy

AU - Garfield, Kirsty

AU - Metcalfe, Chris

AU - Parslow, Roxanne

AU - Downing, Harriet

AU - Kessler, David

AU - Macleod, John

AU - Stallard, Paul

AU - Knoop, Hans

AU - Van de Putte, Elise

AU - Nijhof, Sanne

AU - Bleijenberg, Gijs

AU - Crawley, Esther

PY - 2018/2/22

Y1 - 2018/2/22

N2 - Background: Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a relatively common and disabling condition. The National Institute for Health and Clinical Excellence (NICE) recommends Cognitive Behavioural Therapy (CBT) as a treatment option for paediatric CFS/ME because there is good evidence that it is effective. Despite this, most young people in the UK are unable to access local specialist CBT for CFS/ME. A randomised controlled trial (RCT) showed FITNET was effective in the Netherlands but we do not know if it is effective in the National Health Service (NHS) or if it is cost-effective. This trial will investigate whether FITNET-NHS is clinically effective and cost-effective in the NHS. Methods: Seven hundred and thirty-four paediatric patients (aged 11-17 years) with CFS/ ME will be randomised (1:1) to receive either FITNET-NHS (online CBT) or Activity Management (delivered via video call). The internal pilot study will use integrated qualitative methods to examine the feasibility of recruitment and the acceptability of treatment. The full trial will assess whether FITNET-NHS is clinically effective and cost-effective. The primary outcome is disability at 6 months, measured using the SF-36-PFS (Physical Function Scale) questionnaire. Cost-effectiveness is measured via cost-utility analysis from an NHS perspective. Secondary subgroup analysis will investigate the effectiveness of FITNET-NHS in those with co-morbid mood disorders. Discussion: If FITNET-NHS is found to be feasible and acceptable (internal pilot) and effective and cost-effective (full trial), its provision by the NHS has the potential to deliver substantial health gains for the large number of young people suffering from CFS/ME but unable to access treatment because there is no local specialist service. This trial will provide further evidence evaluating the delivery of online CBT to young people with chronic conditions.

AB - Background: Paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a relatively common and disabling condition. The National Institute for Health and Clinical Excellence (NICE) recommends Cognitive Behavioural Therapy (CBT) as a treatment option for paediatric CFS/ME because there is good evidence that it is effective. Despite this, most young people in the UK are unable to access local specialist CBT for CFS/ME. A randomised controlled trial (RCT) showed FITNET was effective in the Netherlands but we do not know if it is effective in the National Health Service (NHS) or if it is cost-effective. This trial will investigate whether FITNET-NHS is clinically effective and cost-effective in the NHS. Methods: Seven hundred and thirty-four paediatric patients (aged 11-17 years) with CFS/ ME will be randomised (1:1) to receive either FITNET-NHS (online CBT) or Activity Management (delivered via video call). The internal pilot study will use integrated qualitative methods to examine the feasibility of recruitment and the acceptability of treatment. The full trial will assess whether FITNET-NHS is clinically effective and cost-effective. The primary outcome is disability at 6 months, measured using the SF-36-PFS (Physical Function Scale) questionnaire. Cost-effectiveness is measured via cost-utility analysis from an NHS perspective. Secondary subgroup analysis will investigate the effectiveness of FITNET-NHS in those with co-morbid mood disorders. Discussion: If FITNET-NHS is found to be feasible and acceptable (internal pilot) and effective and cost-effective (full trial), its provision by the NHS has the potential to deliver substantial health gains for the large number of young people suffering from CFS/ME but unable to access treatment because there is no local specialist service. This trial will provide further evidence evaluating the delivery of online CBT to young people with chronic conditions.

KW - Activity management

KW - CBT

KW - CFS/ME

KW - Chronic fatigue syndrome

KW - E-counselling

KW - E-health

KW - E-therapy

KW - Myalgic encephalomyelitis

KW - Online systems

KW - Paediatrics

UR - http://www.scopus.com/inward/record.url?scp=85042426607&partnerID=8YFLogxK

U2 - 10.1186/s13063-018-2500-3

DO - 10.1186/s13063-018-2500-3

M3 - Article

VL - 19

SP - 1

EP - 12

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 136

ER -